| Members |
targetComponentId |
| L-glutamin 5 g, pulver till oral lösning |
Product containing only glutamine (medicinal product) |
| L-asparaginas 10 000 IE, pulver till injektionsvätska, flaska 10 ml |
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| disken L4-S1 |
Structure of intervertebral disc of L5 and S1 (body structure) |
| laboratorieprov inlämnat |
Laboratory specimen submitted |
| läpplambå |
Flap (substance) |
| labial fasad, laminat, i samband med konsultation |
Insertion of direct composite veneer onto labial surface of tooth (procedure) |
| labial fasad, porslinslaminat, laboratorium |
Fixation of porcelain veneer onto labial surface of tooth (procedure) |
| labial fasad, plastlaminat, laboratorium |
Fixation of indirect resin veneer onto labial surface of tooth (procedure) |
| Laboratory animal dander allergy |
Allergy to animal protein |
| Laboratory fur-bearing animal |
Class Mammalia (organism) |
| Laboratory test panel |
Laboratory test |
| Labourer |
Laborer |
| Laceration of heart with open wound into thorax AND without penetration of heart chambers |
Laceration of heart |
| laceration av hjärta utan penetration av hjärtrum |
Laceration of heart |
| bilateral laceration av öga utan prolaps eller förlust av intraokulär vävnad |
Laceration of eye |
| Lacrimal apparatus implantation |
Operation on lacrimal system |
| Lacrimal apparatus incision |
Operation on lacrimal system |
| Lacrimal duct catheterised |
Catheterization of nasolacrimal duct |
| Lacrimal duct catheterized |
Catheterization of nasolacrimal duct |
| Lacrimal passage granuloma |
Lacrimal sac granuloma |
| Lactation: [problems] or [& obstetric breast disorders NOS]) |
Disorder of lactation |
| Lactobacillus bavaricus |
Lactobacillus sakei |
| Lactobacillus bavaricus (organism) |
Legionella maceachernii |
| Lactobacillus casei rhamnosus |
Lactobacillus zeae |
| Lactobacillus cellobiosus |
Limosilactobacillus fermentum (organism) |
| Lactobacillus halotolerans |
Weissella halotolerans |
| Lactobacillus kandleri |
Weissella kandleri |
| Lactobacillus maltaromicus |
Carnobacterium maltaromaticum (organism) |
| Lactobacillus minor |
Weissella minor |
| Lactobacillus minutus |
Atopobium minutum |
| Lactobacillus viridescens |
Weissella viridescens |
| Lactobacillus yamanashiensis |
Liquorilactobacillus mali (organism) |
| Lactosphaera pasteurii |
Trichococcus pasteurii (organism) |
| laktulos 10 g/15 ml, sirap |
Product containing precisely lactulose 667 milligram/1 milliliter conventional release oral solution (clinical drug) |
| laminopati, Decaudain Vigouroux-typ |
Familial partial lipodystrophy type 2 (disorder) |
| lamotrigin 200 mg, dispergerbar tablett |
Lamotrigine 200 mg orodispersible tablet |
| lamotrigin 25 mg, dispergerbar tuggtablett |
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Lamotrigine 2mg |
Lamotrigine only product in oral dose form |
| lamotrigin 2 mg, dispergerbar tuggtablett |
Lamotrigine only product in oral dose form |
| lamotrigin 2 mg, tablett till oral suspension |
Lamotrigine only product in oral dose form |
| lamotrigin 50 mg, dispergerbar tablett |
Lamotrigine 50 mg orodispersible tablet |
| lamotrigin 5 mg, dispergerbar tuggtablett |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| Lamotrigine 5mg chewable tablet |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| lamotrigin 5 mg, tablett till oral suspension |
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) |
| histiocytos av Langerhans celler, kategori |
Langerhans' cell histiocytosis |
| patienten har nekat att lämna information om språk |
Refusal by patient to provide information about spoken language (situation) |
| Language not given - patient refused |
Refusal by patient to provide information about spoken language (situation) |
| Language not given - patient refused |
Refusal by patient to provide information about spoken language (situation) |
| lansoprazol 15 mg, enterotablett |
Lansoprazole 15 mg orodispersible tablet |
| lansoprazol 30 mg, enterotablett |
Lansoprazole 30 mg orodispersible tablet |
| lantanumkarbonat 1 g, tuggtablett |
Lanthanum (as lanthanum carbonate) 1 g chewable tablet |
| laparoskopisk ultraljudsundersökning av gallgång och biopsi från gallgångslesion |
Biopsy of lesion of bile duct using laparoscopic ultrasonography guidance (procedure) |
| laparoskopisk ultraljudsundersökning av levern och biopsi från leverlesion |
Laparoscopic ultrasonography guided biopsy of lesion of liver |
| laparoskopisk ultraljudsundersökning av pankreas och biopsi från lesion i pankreas |
Laparoscopic ultrasonography guided biopsy of lesion of pancreas |
| Laparoscopy: [diagnostic female pelvis] or [gynaecological NEC] |
Laparoscopy of female pelvis |
| trakelotomi via laparotomi |
Lower uterine segment caesarean section |
| stor placenta |
Placental volume above reference range (finding) |
| stridor vid laryngospasm |
Laryngeal stridor |
| laryngoonykokutant syndrom |
Laryngo-onycho-cutaneous syndrome (disorder) |
| Laryngoscopy: [diagnostic NOS] or [NEC] |
Laryngoscopy |
| Laser destruction of lesion of organ NOC |
Destruction of lesion by anatomic site |
| Laser destruction of organ NOC |
Destructive procedure by anatomic site |
| Laser excision of lesion of organ NOC |
Excision |
| Laser excision of organ NOC |
Excision |
| Laser therapy to organ NOC |
Laser procedure (procedure) |
| Laser therapy to organ NOC NOS |
Laser procedure (procedure) |
| Laser therapy to organ NOC OS |
Laser procedure (procedure) |
| Late amputation stump complication NOS |
Late amputation stump complication |
| Late amputation stump complication, unspecified |
Late amputation stump complication |
| Late effect of burns of other specified sites, NEC |
Disorder due to and following burn (disorder) |
| Late effect of certain complications of trauma |
Late effect of complications of trauma |
| Late effect of certain other external causes, NEC |
Late effect of injury |
| sena effekter av komplikationer till åtgärd |
Complication of procedure |
| Late effect of injury to other and unspecified nerve |
Disorder due to and following injury to nerve (disorder) |
| Late effect of internal injury to other internal organs |
Late effect of injury to internal organ |
| kronisk oligoartrit med sen debut |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Late operation NOC NOS |
Surgical procedure (procedure) |
| Late operations NOC |
Surgical procedure (procedure) |
| sen stråldermatit |
Dermatitis as late effect of radiation (disorder) |
| lateral buklambå |
Flap (substance) |
| fasciokutan lateral armlambå |
Fasciocutaneous flap |
| fasciokutan lateral armlambå samt humerus |
Osteofasciocutaneous flap (substance) |
| lateral armlambå |
Flap (substance) |
| lateral kalkaneuslambå |
Flap (substance) |
| Lateral canthal ligament |
Structure of lateral palpebral ligament |
| lateral cervikal lambå |
Flap (substance) |
| lateral lambå från ögonlockshud |
Skin flap (substance) |
| lateral fingerlambå |
Flap (substance) |
| lateral musculus gastrocnemius-lambå |
Lateral gastrocnemius muscle flap |
| lateral fasciokutan underbenslambå |
Fasciocutaneous flap |
| lateral underbenslambå |
Flap (substance) |
| lateral plantar lambå |
Flap (substance) |
| lateral tractus rubrospinalis |
Structure of rubrospinal tract (body structure) |
| lateral lårlambå |
Flap (substance) |
| lateral tunglambå |
Flap (substance) |
| Laxator tympani |
Structure of anterior ligament of malleus |
| Layer of fibers of optic nerve of retina |
Structure of nerve fibre layer of retina |
| Le Veenshunt |
Peritoneovenous shunt |
| Leach type |
Leach type (finding) |
| fullföljd hälsohandlingsplan vid inlärningssvårigheter |
Completion of learning disabilities health action plan (procedure) |
| Leather goods maker (general) |
Leather goods maker |
FHIR